Affordable Web-based Foot-ankle Exercise Program Proves Effective for Diabetic Foot Care in a Randomized Controlled Trial with Economic Evaluation

Overview

Journal Sci Rep

Specialty Science

Date 2024 Jul 12

PMID 38997439

Authors

Ronaldo H Cruvinel-Junior

Jane S S P Ferreira

Jady L Verissimo

Renan L Monteiro

Erica Q Silva

Eneida Y Suda

Isabel C N Sacco

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to shed light on a crucial issue through a comprehensive evaluation of the cost-effectiveness and cost-utility of a cutting-edge web-based foot-ankle therapeutic exercise program (SOPeD) designed for treating modifiable risk factors for ulcer prevention in individuals with diabetes-related peripheral neuropathy (DPN). In this randomized controlled trial, 62 participants diagnosed with DPN were assigned to the SOPeD software or received usual care for diabetic foot. Primary outcomes were DPN symptoms and severity, foot pain and function, and quality-adjusted life years (QALYs). Between-group comparisons provided 95% confidence intervals. The study also calculated incremental cost-effectiveness and cost-utility ratios (ICERs), analyzed direct costs from a healthcare perspective, and performed a sensitivity analysis to assess uncertainty. The web-based intervention effectively reduced foot pain, improved foot function and showed favorable cost-effectiveness, with ICERs ranging from (USD) $5.37-$148.71 per improvement in different outcomes. There is a high likelihood of cost-effectiveness for improving DPN symptoms and severity, foot pain, and function, even when the minimum willingness-to-pay threshold was set at $1000.00 USD. However, the intervention did not prove to be cost-effective in terms of QALYs. This study reveals SOPeD's effectiveness in reducing foot pain, improving foot function, and demonstrating cost-effectiveness in enhancing functional and clinical outcomes. SOPeD stands as a potential game-changer for modifiable risk factors for ulcers, with our findings indicating a feasible and balanced integration into public health systems. Further studies and considerations are vital for informed decisions to stakeholders and the successful implementation of this preventive program on a larger scale.Trial Registration: ClinicalTrials.gov, NCT04011267. Registered on 8 July 2019.

References

Altman D, Bland J . How to randomise. BMJ. 1999; 319(7211):703-4. PMC: 1116549. DOI: 10.1136/bmj.319.7211.703. View

Pop-Busui R, Boulton A, Feldman E, Bril V, Freeman R, Malik R . Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2016; 40(1):136-154. PMC: 6977405. DOI: 10.2337/dc16-2042. View

van Netten J, Sacco I, Lavery L, Monteiro-Soares M, Paton J, Rasmussen A . Clinical and biomechanical effectiveness of foot-ankle exercise programs and weight-bearing activity in people with diabetes and neuropathy: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2023; 40(3):e3649. DOI: 10.1002/dmrr.3649. View

Sartor C, Hasue R, Cacciari L, Butugan M, Watari R, Passaro A . Effects of strengthening, stretching and functional training on foot function in patients with diabetic neuropathy: results of a randomized controlled trial. BMC Musculoskelet Disord. 2014; 15:137. PMC: 4031603. DOI: 10.1186/1471-2474-15-137. View

Dowie J . Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Econ. 2002; 11(1):1-8. DOI: 10.1002/hec.667. View

Pereda P, Boarati V, Guidetti B, Duran A . Direct and Indirect Costs of Diabetes in Brazil in 2016. Ann Glob Health. 2022; 88(1):14. PMC: 8896241. DOI: 10.5334/aogh.3000. View

Andersen H, Gjerstad M, Jakobsen J . Atrophy of foot muscles: a measure of diabetic neuropathy. Diabetes Care. 2004; 27(10):2382-5. DOI: 10.2337/diacare.27.10.2382. View

Raftery J, Williams H, Clarke A, Thornton J, Norrie J, Snooks H . 'Not clinically effective but cost-effective' - paradoxical conclusions in randomised controlled trials with 'doubly null' results: a cross-sectional study. BMJ Open. 2020; 10(1):e029596. PMC: 6955496. DOI: 10.1136/bmjopen-2019-029596. View

Fernando M, Crowther R, Lazzarini P, Sangla K, Cunningham M, Buttner P . Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clin Biomech (Bristol). 2013; 28(8):831-45. DOI: 10.1016/j.clinbiomech.2013.08.004. View

10.

Shun C, Chang Y, Wu H, Hsieh S, Lin W, Lin Y . Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain. 2004; 127(Pt 7):1593-605. DOI: 10.1093/brain/awh180. View

11.

de Cassia Ernandes R, Brech G, Luna N, Bega A, GuimarAes D, Bocalini D . IMPACT OF DIABETIC NEUROPATHY ON QUALITY OF LIFE AND POSTURAL BALANCE IN BRAZILIAN OLDER ADULTS. Acta Ortop Bras. 2020; 28(6):275-279. PMC: 7723388. DOI: 10.1590/1413-785220202806234529. View

12.

Guindo L, Wagner M, Baltussen R, Rindress D, van Til J, Kind P . From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking. Cost Eff Resour Alloc. 2012; 10(1):9. PMC: 3495194. DOI: 10.1186/1478-7547-10-9. View

13.

Sacco I, Hamamoto A, Tonicelli L, Watari R, Ortega N, Sartor C . Abnormalities of plantar pressure distribution in early, intermediate, and late stages of diabetic neuropathy. Gait Posture. 2014; 40(4):570-4. DOI: 10.1016/j.gaitpost.2014.06.018. View

14.

Santos M, A C T Cintra M, Monteiro A, Santos B, Gusmao-Filho F, Andrade M . Brazilian Valuation of EQ-5D-3L Health States: Results from a Saturation Study. Med Decis Making. 2015; 36(2):253-63. DOI: 10.1177/0272989X15613521. View

15.

Schaper N, van Netten J, Apelqvist J, Bus S, Hinchliffe R, Lipsky B . Practical Guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes Metab Res Rev. 2020; 36 Suppl 1:e3266. DOI: 10.1002/dmrr.3266. View

16.

Lo Z, Surendra N, Saxena A, Car J . Clinical and economic burden of diabetic foot ulcers: A 5-year longitudinal multi-ethnic cohort study from the tropics. Int Wound J. 2021; 18(3):375-386. PMC: 8244009. DOI: 10.1111/iwj.13540. View

17.

Ferreira J, Cruvinel Junior R, Silva E, Verissimo J, Monteiro R, Pereira D . Study protocol for a randomized controlled trial on the effect of the Diabetic Foot Guidance System (SOPeD) for the prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial I. Trials. 2020; 21(1):73. PMC: 6958734. DOI: 10.1186/s13063-019-4017-9. View

18.

Suryani M, Samekto W, Heri-Nugroho , Susanto H, Dwiantoro L . Effect of foot-ankle flexibility and resistance exercise in the secondary prevention of plantar foot diabetic ulcer. J Diabetes Complications. 2021; 35(9):107968. DOI: 10.1016/j.jdiacomp.2021.107968. View

19.

Sartor C, Oliveira M, Campos V, Ferreira J, Sacco I . Cross-cultural adaptation and measurement properties of the Brazilian Version of the Michigan Neuropathy Screening Instrument. Braz J Phys Ther. 2017; 22(3):222-230. PMC: 5993960. DOI: 10.1016/j.bjpt.2017.10.004. View

20.

Sacco I, Hamamoto A, A Gomes A, Onodera A, Hirata R, Hennig E . Role of ankle mobility in foot rollover during gait in individuals with diabetic neuropathy. Clin Biomech (Bristol). 2009; 24(8):687-92. DOI: 10.1016/j.clinbiomech.2009.05.003. View